Form D · Biotechnology
IGM Biosciences A/S
Kongens Lyngby, G7 · CIK 0001727622
Offering snapshot reported Jan 16, 2018 · SEC filing
- Reported sold
- $2.13M Offering amount: $2.35M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $1.03K Reported outside-investor minimum
- First sale
- Dec 29, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 16, 2018 | Initial | $2,132,298 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-303330
Source: Form D, filed Jan 16, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hans Kornerup | Executive |
| Jakob Haldor Topsoe | Director |
| Christina Topsoe | Director |
| Henrik Topsoe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Haldor Topsoes Alle 1
Kongens Lyngby, G7, 2800
Kongens Lyngby, G7, 2800